| 摘要 |
A pharmaceutical composition comprising ginseng or lactobacillus-fermented ginseng is provided to treat colitis including ulcerative colitis and Crohn's disease without side effects. The pharmaceutical composition comprises ginseng extract or lactobacillus-fermented ginseng, wherein the composition further comprises lactic acid bacteria including Lactobacillus sp., Streptococcus sp. or Bifidobacterium sp.. The lactic acid bacterium is Bifidobacterium K-103, Bifidobacterium K-506, Bifidobacterium cholerium KK-1, Bifidobacterium minimum KK-2, Bifidobacterium H-1 or Bifidobacterium KK-11. The ginseng extract contains at least one ginseng saponin derivative selected from ginsenoside Ra, Rb1, Rb2, Rc, Rd, Rg3, F2, Re, Rf, Rg1, Rg2, Rh2, Rh1, Rh3, Rh4, Rk1, Rk2, Rk3, Rg5, protopanaxadiol, protopanaxatriol or compound K(20-0-beta-D-glucopyranosyl-20(S)-protopanaxadiol).
|
